The Journal of Heart and Lung Transplantation
Volume 29, Issue 9 , Pages 1021-1025 , September 2010

Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement

  • Eric S. Ketchum, MD

      Affiliations

    • Division of Cardiology, University of Washington, Seattle, Washington
    • ,
  • Alec J. Moorman, MD

      Affiliations

    • Division of Cardiology, University of Washington, Seattle, Washington
    • ,
  • Daniel P. Fishbein, MD

      Affiliations

    • Division of Cardiology, University of Washington, Seattle, Washington
    • ,
  • Nahush A. Mokadam, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
    • ,
  • Edward D. Verrier, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
    • ,
  • Gabriel S. Aldea, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
    • ,
  • Shauna Andrus, BSN, RN

      Affiliations

    • Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington
    • ,
  • Kenneth W. Kenyon, PharmD

      Affiliations

    • Division of Cardiology, University of Washington, Seattle, Washington
    • ,
  • Wayne C. Levy, MD

      Affiliations

    • Division of Cardiology, University of Washington, Seattle, Washington
    • Corresponding Author InformationReprint requests: Wayne C. Levy, MD, Division of Cardiology, University of Washington, Box 356422, 1959 NE Pacific Street, Seattle, WA 98177. Telephone: 206-221-4507. Fax: 206-221-6835

References 

  1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:480–486
  2. Taylor DO, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report—2008. J Heart Lung Transplant. 2008;27:943–956
  3. Aaronson KD, Eppinger MJ, Dyke DB, et al. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol. 2002;39:1247–1254
  4. Holman WL, Kormos RL, Naftel DC, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009;28:44–50
  5. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53:e1–e90
  6. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433
  7. May HT, Horne BD, Levy WC, et al. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide. Am J Cardiol. 2007;100:697–700
  8. Giamouzis G, Kalogeropoulos AP, Georgiopoulou VV, et al. Incremental value of renal function in risk prediction with the Seattle Heart Failure Model. Am Heart J. 2009;157:299–305
  9. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, et al. Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol. 2009;53:334–342
  10. Levy WC, Mozaffarian D, Linker DT, et al. Can the Seattle Heart Failure Model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?. J Heart Lung Transplant. 2009;28:231–236
  11. Levy W, Lee K, Hellkamp A, et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation. 2009;120:835–842
  12. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  13. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129:9–17
  14. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–2251
  15. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1–10
  16. Alba AC, Rao V, Ivanov J, et al. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant. 2009;28:827–833
  17. Schaffer JM, Allen JG, Weiss ES, et al. Evaluation of risk indices in continuous-flow left ventricular assist device patients. Ann Thorac Surg. 2009;88:1889–1896
  18. Vongooru H, Basraon J, Agnihotri A, et al. Survival estimation by Seattle Heart Failure Model and Heart Failure Survival Score in patients undergoing elective left ventricular assist device placement. J Card Failure. 2009;15(suppl):S54
  19. Strueber M, Birks E, Jansz P, et al. Clinical results of the International HeartWare LVAS Bridge to Transplant Trial. J Heart Lung Transplant. 2009;28(suppl 1):S255
  20. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–896

PII: S1053-2498(10)00283-4

doi: 10.1016/j.healun.2010.05.002

The Journal of Heart and Lung Transplantation
Volume 29, Issue 9 , Pages 1021-1025 , September 2010

Article Tools

* Image Usage & Resolution